about
Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound.Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds.Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders.Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.Experimental inflammation following dural application of complete Freund's adjuvant or inflammatory soup does not alter brain and trigeminal microvascular passage.Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.Does sumatriptan cross the blood-brain barrier in animals and man?The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis.Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.Role of calcitonin gene-related peptide (CGRP) in ovine burn and smoke inhalation injury.Migraine pain: reflections against vasodilatation.Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.History of migraine with aura and cortical spreading depression from 1941 and onwards.The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine.5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?The extracranial vascular theory of migraine: an artificial controversy.Pathophysiology of Migraine: A Disorder of Sensory Processing.The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.Side effects associated with current and prospective antimigraine pharmacotherapies.Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches.Recognizing the role of CGRP and CGRP receptors in migraine and its treatment.A Comparative Study of Orally Delivered PBCA and ApoE Coupled BSA Nanoparticles for Brain Targeting of Sumatriptan Succinate in Therapeutic Management of Migraine.Concentration effects of sumatriptan on the properties of model membranes by molecular dynamics simulations.Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia.
P2860
Q30370894-320A58D3-53EB-4AB4-B955-5ACEE34FF102Q33573290-D5A9BC73-3FF7-4DAB-A701-9CFDBF5CA654Q33778781-E2915592-B88A-4679-A64E-CC332510C32CQ34180539-22EE5FE6-8433-44AD-84AF-098E4F9BD9DBQ34304978-7C1753B8-9877-49C0-AA6F-39354F624425Q34727128-EB408B3B-E695-4A91-9FE7-7B148575AE63Q36233055-D201C8A0-151B-4F9E-8964-CA6318441AC4Q36260321-CCB141F9-D95B-4307-B4EC-F4CEED89DEA1Q36260908-3655A21D-3F35-4EB6-A8C9-AAACD8267922Q36340711-D59C99CA-6885-4CF5-9C3A-3A176C7B4D00Q37081979-AF13A41A-5846-400A-8FDB-29EEDD9478C0Q37264623-6E7C6703-8D87-4847-89E9-C5BD90BB0AEBQ37508771-FAB516DA-975B-4D10-8C8C-EF453387BCF0Q37558868-DD7C0313-124C-4FF0-8AB3-DA5F2054D509Q37594152-213EDE44-1CC1-49DF-84F9-600517481FCFQ37713262-B79F7B64-1009-4E0F-AB73-74AD0A7A5042Q37739587-4C3E6849-B5F8-4A3D-9890-A5FE6F3F8BF4Q37826098-DC21F5BB-4AD7-4228-8B58-CA237B857AD0Q39127073-BED46FE4-B743-423F-9096-885D29FEE7E0Q41829270-25A76D0D-307A-4F07-80D0-B5B99AC39D22Q47309054-4A1FC832-CA24-4748-8E9C-D0D3830C416EQ47676203-7591D46F-1E00-415E-8549-B059559D317EQ47819343-D38CD79A-1F01-41E6-AFCE-E490B32110DAQ48818624-D5945B11-0D51-4617-9637-225C4215EF18Q48967820-52C45468-876B-48DB-9B2B-C15D548DF02CQ52096863-A8E730F4-7F4F-4DF2-99E1-497BBEF46176
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The blood-brain barrier in migraine treatment.
@en
The blood-brain barrier in migraine treatment.
@nl
type
label
The blood-brain barrier in migraine treatment.
@en
The blood-brain barrier in migraine treatment.
@nl
prefLabel
The blood-brain barrier in migraine treatment.
@en
The blood-brain barrier in migraine treatment.
@nl
P2860
P1433
P1476
The blood-brain barrier in migraine treatment.
@en
P2860
P304
P356
10.1111/J.1468-2982.2008.01675.X
P407
P577
2008-08-22T00:00:00Z